Navigation Links
Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
Date:3/7/2012

CRANBURY, N.J., March 7, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) announced that it will be presenting at the 24th Annual ROTH OC Growth Stock Conference on Tuesday, March 13, 2012, at 1:30 p.m. Pacific Time.  The conference will be held at the Ritz Carlton Laguna Niguel in Dana Point, CA.

Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs. A live audio broadcast will be available on the "Investors" section of Palatin's website at www.palatin.com. The live audio broadcast will be available through March 20, 2012.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor- specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin's website at www.palatin.com.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
3. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
4. Palatin Technologies to Present at 10th Annual BIO Investor Forum
5. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results
6. Palatin Technologies, Inc. to Report Fiscal Year 2011 Fourth Quarter Results; Teleconference and Webcast to be held on September 22, 2011
7. Palatin Technologies, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference
8. Palatin Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca
9. Palatin Technologies, Inc. Announces Presentation and Publication on Validation of Scale for Subjective Male Sexual Arousal
10. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results
11. Palatin Technologies, Inc. Announces Results of Annual Stockholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... ... March 20, 2017 , ... SSCI and Whitehouse Laboratories, ... INTERPHEX 2017 ! Sponsored by the Parenteral Drug Association (PDA), the New ... over 12,000 industry professionals in attendance and more than 625 exhibitors, the educational and ...
(Date:3/20/2017)... ... March 20, 2017 , ... Avexegen Therapeutics Inc., an ... it has entered into an exclusive global license agreement with Children’s Hospital Los ... Enterocolitis (rare orphan disease) as well as Crohn’s Disease and Ulcerative Colitis. ...
(Date:3/20/2017)... ... March 20, 2017 , ... The fourth annual Hackaday Prize ... make an extraordinary impact on peoples’ lives, launches today. Sponsored by Digi-Key ... weeks and awards thousands in cash prizes to engineers, inventors and tinkerers who “build ...
(Date:3/20/2017)... Wash. , March 20, 2017 Western ... provider of ethical review of clinical research, announced today ... Solution TM (SRS) for NIH-funded multi-site research. ... its 2,300 institution clients, WIRB has an extensive background ... our trusted status as the IRB of record for ...
Breaking Biology Technology:
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special ... Kephart of Identity Strategy Partners, LLP, today releases ... "Executive Order: Protecting the Nation From Foreign Terrorist Entry ... "As President Trump,s ,Travel Ban, Executive Order gains more ... the travel ban, it is important that our national ...
Breaking Biology News(10 mins):